Teton Advisors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Teton Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Teton Advisors from 13F filings

Historical chart of Teton Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Teton Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Teton Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $375k 400k 0.94

More positions owned by Teton Advisors

Nathan's Famous Equity (NATH)
Myers Industries Equity (MYE)
Modine Manufacturing Equity (MOD)
Astec Industries Equity (ASTE)
Ducommun Equity (DCO)
Distribution Solutions Group Equity (DSGR)
Gencor Industries Equity (GENC)
Cts Corp Equity (CTS)
Gibraltar Industries Equity (ROCK)
Eastern Co/the Equity (EML)
Marine Products Corp Equity (MPX)
Rush Enterprises Inc - Cl B Equity (RUSHB)
Flushing Financial Corp Equity (FFIC)
Federal Signal Corp Equity (FSS)
Golden Entertainment Equity (GDEN)

View all positions for Teton Advisors

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1